-
公开(公告)号：US20180297985A1
公开(公告)日：2018-10-18
申请号：US15818082
申请日：2017-11-20
Applicant: Array BioPharma, Inc.
Inventor： Shenlin Huang , Xianming Jin , Zuosheng Liu , Daniel Poon , John Tellew , Yongqin Wan , Xing Wang , Yongping Xie
IPC: C07D403/04 , A61K31/4184 , A61K9/00 , C07D405/14 , C07D401/14 , A61K45/06 , A61K31/506
Abstract: The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
-
公开(公告)号：US10568884B2
公开(公告)日：2020-02-25
申请号：US15818264
申请日：2017-11-20
Applicant: Array BioPharma, Inc.
Inventor： Shenlin Huang , Xianming Jin , Zuosheng Liu , Daniel Poon , John Tellew , Yongqin Wan , Xing Wang , Yongping Xie
IPC: A61K31/506 , A61K31/4184 , A61K9/00 , C07D405/14 , A61K45/06 , C07D403/04 , C07D401/14
Abstract: The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
-
公开(公告)号：USRE49556E1
公开(公告)日：2023-06-20
申请号：US17376199
申请日：2021-07-15
Applicant: Array BioPharma Inc.
Inventor： Shenlin Huang , Xianming Jin , Zuosheng Liu , Daniel Poon , John Tellew , Yongqin Wan , Xing Wang , Yongping Xie
IPC: A61K31/506 , A61K9/00 , A61K31/4184 , A61K45/06 , C07D401/14 , C07D403/04 , C07D405/14
CPC classification number: A61K31/506 , A61K9/0053 , A61K31/4184 , A61K45/06 , C07D401/14 , C07D403/04 , C07D405/14 , A61K31/506 , A61K2300/00
Abstract: The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
-
公开(公告)号：US20180297986A1
公开(公告)日：2018-10-18
申请号：US15818264
申请日：2017-11-20
Applicant: Array BioPharma, Inc.
Inventor： Shenlin Huang , Xianming Jin , Zuosheng Liu , Daniel Poon , John Tellew , Yongqin Wan , Xing Wang , Yongping Xie
IPC: C07D403/04 , A61K31/4184 , A61K9/00 , C07D405/14 , C07D401/14 , A61K45/06 , A61K31/506
Abstract: The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
-
公开(公告)号：US20230116233A1
公开(公告)日：2023-04-13
申请号：US17724589
申请日：2022-04-20
Applicant: Array BioPharma Inc.
Inventor： Shenlin Huang , Xianming Jin , Zuosheng Liu , Daniel Poon , John Tellew , Yongqin Wan , Xing Wang , Yongping Xie
IPC: A61K31/506 , C07D401/14 , C07D403/04 , A61K45/06 , C07D405/14 , A61K9/00 , A61K31/4184
Abstract: The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
-
Patent Agency Ranking
公开(公告)号：US20200323852A1
公开(公告)日：2020-10-15
申请号：US16741937
申请日：2020-01-14
Applicant: Array BioPharma Inc.
Inventor： Shenlin Huang , Xianming Jin , Zuosheng Liu , Daniel Poon , John Tellew , Yongqin Wan , Xing Wang , Yongping Xie
IPC: A61K31/506 , C07D401/14 , C07D403/04 , A61K45/06 , C07D405/14 , A61K9/00 , A61K31/4184
Abstract: The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
-
公开(公告)号：US10576080B2
公开(公告)日：2020-03-03
申请号：US15818082
申请日：2017-11-20
Applicant: Array BioPharma, Inc.
Inventor： Shenlin Huang , Xianming Jin , Zuosheng Liu , Daniel Poon , John Tellew , Yongqin Wan , Xing Wang , Yongping Xie
IPC: A61K31/506 , A61K31/4184 , A61K9/00 , C07D405/14 , A61K45/06 , C07D403/04 , C07D401/14
Abstract: The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
-
公开(公告)号：US10005761B2
公开(公告)日：2018-06-26
申请号：US15070905
申请日：2016-03-15
Applicant: Array BioPharma, Inc.
Inventor： Shenlin Huang , Xianming Jin , Zuosheng Liu , Daniel Poon , John Tellew , Yongqin Wan , Xing Wang , Yongping Xie
IPC: A61K31/535 , C07D403/04 , C07D401/14 , A61K31/506 , A61K45/06 , C07D405/14 , A61K9/00 , A61K31/4184
CPC classification number: A61K31/506 , A61K9/0053 , A61K31/4184 , A61K45/06 , C07D401/14 , C07D403/04 , C07D405/14 , A61K2300/00
Abstract: The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
-
公开(公告)号：US09850230B2
公开(公告)日：2017-12-26
申请号：US15179644
申请日：2016-06-10
Applicant: Array BioPharma, Inc.
Inventor： Shenlin Huang , Xianming Jin , Zuosheng Liu , Daniel Poon , John Tellew , Yongqin Wan , Xing Wang , Yongping Xie
IPC: C07D401/00 , C07D403/04 , C07D401/14 , A61K31/506 , A61K45/06 , C07D405/14 , A61K9/00 , A61K31/4184
CPC classification number: C07D403/04 , A61K9/0053 , A61K31/4184 , A61K31/506 , A61K45/06 , C07D401/14 , C07D405/14 , A61K2300/00
Abstract: The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
-
公开(公告)号：US09593099B2
公开(公告)日：2017-03-14
申请号：US14994710
申请日：2016-01-13
Applicant: Array BioPharma, Inc.
Inventor： Shenlin Huang , Xianming Jin , Zuosheng Liu , Daniel Poon , John Tellew , Yongqin Wan , Xing Wang , Yongping Xie
IPC: A61K31/535 , C07D403/04 , C07D401/14 , A61K31/506 , A61K45/06 , C07D405/14 , A61K9/00 , A61K31/4184
CPC classification number: C07D403/04 , A61K9/0053 , A61K31/4184 , A61K31/506 , A61K45/06 , C07D401/14 , C07D405/14 , A61K2300/00
Abstract: The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
-
-
-
-
-
-
-
-
-
Search Results
12
records
(took 0.05 seconds)
